Latest Parkinson's disease Stories
Nationwide strategic health initiative aims to fill in knowledge gaps and connect patients and caregivers to local resources and one-on-one support NEW YORK, May 27, 2014 /PRNewswire-USNewswire/
--Research Includes Stem Cells, Imaging and Exercise for Cognition-- MIAMI, May 22, 2014 /PRNewswire-USNewswire/ -- The National
Beneufit's first product pdFIT(TM), uses cycling to help Parkinson's disease patients fight symptoms and disease progression SAN FRANCISCO, May 21, 2014 /PRNewswire/ --
Transparency Market Research published a new report "Deep Brain Stimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report
A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.
Vick is one of less than 100 clinicians across the state, and one of 1,600 worldwide, to earn this certification, according to LSVT Global. Franklin, Va.
Positive Clinician-Reported Patient Assessments Consistent with Earlier Findings Reported with ADS-5102 EMERYVILLE, Calif., April 30, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc.
GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment
PHILADELPHIA, April 28, 2014 /PRNewswire-USNewswire/ -- A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds
NEW YORK, April 28, 2014 /PRNewswire-USNewswire/ -- Founder Michael J. Fox; CEO Todd Sherer, PhD; and Co-Founder and Executive Vice Chairman Deborah W. Brooks of The Michael J.
- totally perplexed and mixed up.
More Images (1 images) »